id
stringlengths 1
5
| question_id
stringlengths 1
5
| document_id
stringlengths 5
7
| question
stringlengths 55
970
| type
stringclasses 1
value | choices
list | context
stringlengths 0
971
| answer
sequence |
---|---|---|---|---|---|---|---|
100 | 109 | 2871176 | Compared to Placebo plus glimepiride what was the result of Rosiglitazone plus glimepiride on HbA1c level at 26 weeks? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The proportion of subjects experiencing minor hypoglycaemia during the trial was lowest with placebo (i.e. glimepiride monotherapy 2.6%; 0.17 events/subject-year), comparable with liraglutide 0.6 mg (5.2%, 0.17 events/subject-year) and rosiglitazone (4.3%, 0.12 events/subject-year) groups and similar between the liraglutide 1.2 mg (9.2%, 0.51 events/subject-year) and liraglutide 1.8 mg (8.1%, 0.47 events/subject-year) treatment groups. Incidence was higher with liraglutide 1.2 mg (P = 0.0024) and 1.8 mg (P = 0.0065) compared with rosiglitazone and liraglutide 1.2 mg compared with placebo (P = 0.048), occurring in the setting of lower mean HbA1c values. | [
"significantly decreased"
] |
101 | 146 | 2871176 | Compared to Rosiglitazone plus glimepiride what was the result of Liraglutide (all doses) plus glimepiride on Decreases in diastolic blood pressure? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The proportion of subjects experiencing minor hypoglycaemia during the trial was lowest with placebo (i.e. glimepiride monotherapy 2.6%; 0.17 events/subject-year), comparable with liraglutide 0.6 mg (5.2%, 0.17 events/subject-year) and rosiglitazone (4.3%, 0.12 events/subject-year) groups and similar between the liraglutide 1.2 mg (9.2%, 0.51 events/subject-year) and liraglutide 1.8 mg (8.1%, 0.47 events/subject-year) treatment groups. Incidence was higher with liraglutide 1.2 mg (P = 0.0024) and 1.8 mg (P = 0.0065) compared with rosiglitazone and liraglutide 1.2 mg compared with placebo (P = 0.048), occurring in the setting of lower mean HbA1c values. | [
"no significant difference"
] |
102 | 205 | 4106715 | Compared to placebo what was the result of low Ab group on Prolonged abstinence from smoking rates to 12 months? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | 3'AmNic-rEPA recipients with the highest serum anti-nicotine antibody response (top 30% by AUC) were significantly more likely to attain 8 weeks continuous abstinence from weeks 19 through 26 than the placebo recipients (24.6% vs. 12.0%, p=0.024, OR=2.69, 95% CI, 1.14–6.37). | [
"no significant difference"
] |
103 | 93 | 2944158 | Compared to staff inclination replacement what was the result of routine replacement on infiltration? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | For individual IVD dwell times, the clinically indicated group devices had a median dwell time of 85 hours (quartiles 51 and 121 hours), and those replaced routinely had a median dwell time of 71 hours (quartiles 48 and 90 hours) (P < 0.001). | [
"no significant difference"
] |
104 | 192 | 1852268 | Compared to Intravenous piperacillin–tazobactam, 3.375 g every 6 hours what was the result of Inravenous ertapenem, 1 g once a day on obstetric/postpartum infection or gynecologic/postoperative infection? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At the primary efficacy endpoint 2–4 weeks post therapy, 93.9% of patients
who received ertapenem and 91.5% of those who received piperacillin–tazobactam were cured (95%
confidence interval for the difference, adjusting for strata, –4% to 8.8%), indicating that cure rates for both
treatment groups were equivalent. | [
"no significant difference"
] |
105 | 110 | 2871176 | Compared to Placebo plus glimepiride what was the result of Liraglutide (1.2 mg) plus glimepiride on Patients reaching HbA1c goals less than 7.0% and equal or less than 6.5%? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The proportion of subjects experiencing minor hypoglycaemia during the trial was lowest with placebo (i.e. glimepiride monotherapy 2.6%; 0.17 events/subject-year), comparable with liraglutide 0.6 mg (5.2%, 0.17 events/subject-year) and rosiglitazone (4.3%, 0.12 events/subject-year) groups and similar between the liraglutide 1.2 mg (9.2%, 0.51 events/subject-year) and liraglutide 1.8 mg (8.1%, 0.47 events/subject-year) treatment groups. Incidence was higher with liraglutide 1.2 mg (P = 0.0024) and 1.8 mg (P = 0.0065) compared with rosiglitazone and liraglutide 1.2 mg compared with placebo (P = 0.048), occurring in the setting of lower mean HbA1c values. | [
"significantly increased"
] |
106 | 100 | 2871176 | Compared to Rosiglitazone plus glimepiride what was the result of Liraglutide (1.2 mg) plus glimepiride on HbA1c level at 26 weeks? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The proportion of subjects experiencing minor hypoglycaemia during the trial was lowest with placebo (i.e. glimepiride monotherapy 2.6%; 0.17 events/subject-year), comparable with liraglutide 0.6 mg (5.2%, 0.17 events/subject-year) and rosiglitazone (4.3%, 0.12 events/subject-year) groups and similar between the liraglutide 1.2 mg (9.2%, 0.51 events/subject-year) and liraglutide 1.8 mg (8.1%, 0.47 events/subject-year) treatment groups. Incidence was higher with liraglutide 1.2 mg (P = 0.0024) and 1.8 mg (P = 0.0065) compared with rosiglitazone and liraglutide 1.2 mg compared with placebo (P = 0.048), occurring in the setting of lower mean HbA1c values. | [
"significantly decreased"
] |
107 | 204 | 4106715 | Compared to placebo what was the result of high Ab group on Prolonged abstinence from smoking rates to 12 months? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | 3'AmNic-rEPA recipients with the highest serum anti-nicotine antibody response (top 30% by AUC) were significantly more likely to attain 8 weeks continuous abstinence from weeks 19 through 26 than the placebo recipients (24.6% vs. 12.0%, p=0.024, OR=2.69, 95% CI, 1.14–6.37). | [
"significantly increased"
] |
108 | 138 | 2871176 | Compared to Placebo plus glimepiride what was the result of Liraglutide (1.8 mg) plus glimepiride on HOMA-B? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The proportion of subjects experiencing minor hypoglycaemia during the trial was lowest with placebo (i.e. glimepiride monotherapy 2.6%; 0.17 events/subject-year), comparable with liraglutide 0.6 mg (5.2%, 0.17 events/subject-year) and rosiglitazone (4.3%, 0.12 events/subject-year) groups and similar between the liraglutide 1.2 mg (9.2%, 0.51 events/subject-year) and liraglutide 1.8 mg (8.1%, 0.47 events/subject-year) treatment groups. Incidence was higher with liraglutide 1.2 mg (P = 0.0024) and 1.8 mg (P = 0.0065) compared with rosiglitazone and liraglutide 1.2 mg compared with placebo (P = 0.048), occurring in the setting of lower mean HbA1c values. | [
"no significant difference"
] |
109 | 199 | 3187863 | Compared to Normal unit & Special unit what was the result of Midwife-led unit on Neonatal outcomes were evaluated by Apgar score <7 at 5 minutes, metabolic acidosis and transfer to NICU within 2 hours of birth? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Of all women randomised to the MU, 15.8% had an epidural, which is a significantly lower rate than 23.3% in the NU (RR 1.47, 95% CI 1.11–1.96) and 24.8% in the SU (RR 1.57, 95% CI 1.16–2.13). | [
"no significant difference"
] |
110 | 119 | 2871176 | Compared to Placebo plus glimepiride what was the result of Liraglutide (1.2 mg) plus glimepiride on ADA fasting plasma glucose goals between 5.0 mmol/l and less than 7.2 mmol/l? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The proportion of subjects experiencing minor hypoglycaemia during the trial was lowest with placebo (i.e. glimepiride monotherapy 2.6%; 0.17 events/subject-year), comparable with liraglutide 0.6 mg (5.2%, 0.17 events/subject-year) and rosiglitazone (4.3%, 0.12 events/subject-year) groups and similar between the liraglutide 1.2 mg (9.2%, 0.51 events/subject-year) and liraglutide 1.8 mg (8.1%, 0.47 events/subject-year) treatment groups. Incidence was higher with liraglutide 1.2 mg (P = 0.0024) and 1.8 mg (P = 0.0065) compared with rosiglitazone and liraglutide 1.2 mg compared with placebo (P = 0.048), occurring in the setting of lower mean HbA1c values. | [
"significantly increased"
] |
111 | 400 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Complications after surgery? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"no significant difference"
] |
112 | 472 | 2847809 | Compared to Placebo what was the result of Clopidogrel on Complications and mortality? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The primary AVF failures at two months were 21.6% in placebo group and 5.2% in clopidogrel group (P = 0.03). | [
"no significant difference"
] |
113 | 344 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Time to first COPD exacerbation? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
114 | 474 | 2847809 | Compared to Placebo what was the result of Clopidogrel on The primary arteriovenous fistula failures at two months? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The primary AVF failures at two months were 21.6% in placebo group and 5.2% in clopidogrel group (P = 0.03). | [
"significantly decreased"
] |
115 | 315 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on 1-hour post-dose FEV1 improvements? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
116 | 480 | 2447617 | Compared to placebo what was the result of progesterone on The analysis using the dichotomization of GOS scores at 6 months post injury? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The percentage of favorable outcome was 58% for the patients who were given progesterone and was 42% in the placebo group (P = 0.048). Forty-one percent of patients who were given progesterone and 57% of the placebo group exhibited an unfavorable outcome (P = 0.048). | [
"significantly increased"
] |
117 | 324 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Mean FEV1 at 12 hours at end of treatment? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
118 | 406 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Scar width? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"significantly decreased"
] |
119 | 481 | 2899760 | Compared to anterior cervical decompression and fusion (ACDF) with Trabecular MetalTM (TM) what was the result of raditional Smith–Robinson (SR) procedure with autograft on Fusion rate? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | usion rate in the SR group was 92%, and in the TM group 69% (P < 0.05). | [
"significantly increased"
] |
120 | 224 | 1475568 | Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Minnesota living with heart failure (MLHF) questionnaire baseline scores? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline. | [
"significantly decreased"
] |
121 | 374 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 160/9 μg on Sleep score improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
122 | 319 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Peak expiratory flow in the morning and evening ? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
123 | 440 | 2600646 | Compared to dihydroartemisinin-piperaquine (AP) what was the result of arthemeter-lumefantrine (AL) on mean Hb? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Final mean Hb levels were 7.15 mmol/l ± 1.07 for the DP treatment group and 6.79 mmol/l ± 1.24 for the AL group. A possible influence of anaemia on gametocyte carriage at enrollment was not observed in the present study (p > 0.05). | [
"no significant difference"
] |
124 | 268 | 2691927 | Compared to Conventional open approach what was the result of Laparoscopic surgery on Need for opiates? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure. | [
"significantly decreased"
] |
125 | 241 | 3090298 | Compared to Thin-flap laser in situ keratomileusis (LASIK) what was the result of Photo-refractive keratectomy (PRK) on Higher-order aberrations during the study? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63. | [
"no significant difference"
] |
126 | 216 | 1475568 | Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Heart failure-related quality of life at the end of treatment? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline. | [
"no significant difference"
] |
127 | 326 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Baseline-adjusted average 12-hour FEV1 at end of treatment? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
128 | 443 | 1468428 | Compared to no enema what was the result of 1 litre saline enema on Puerperal and neonatal infection rates ? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | We found no significant differences in puerperal or neonatal infection rates (Puerperal infection: 41/190 [22%] with enema v 26/182 [14%] without enema; RR 0.66 CI 95%: 0.43 to 1.03; neonatal infection 38/191 [20%] with enema v 40/179 [22%] without enema; RR 1.12, 95% CI 95% 0.76 to 1.66) | [
"no significant difference"
] |
129 | 341 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on 1-hour post-dose inspiratory capacity mean improvements from baseline to the average over the randomized treatment period? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
130 | 403 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Infection of the surgical site? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"no significant difference"
] |
131 | 347 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Amount of exacerbations per patient-treatment year? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly decreased"
] |
132 | 231 | 3090298 | Compared to Thin-flap laser in situ keratomileusis (LASIK) what was the result of Photo-refractive keratectomy (PRK) on Uncorrected distance visual acuity at 1 month? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63. | [
"significantly decreased"
] |
133 | 389 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Smaller incision ? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"significantly increased"
] |
134 | 482 | 2899760 | Compared to anterior cervical decompression and fusion (ACDF) with Trabecular MetalTM (TM) what was the result of raditional Smith–Robinson (SR) procedure with autograft on clinical outcomes? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | usion rate in the SR group was 92%, and in the TM group 69% (P < 0.05). | [
"no significant difference"
] |
135 | 367 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Overall use of daily rescue medication improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
136 | 402 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Urinary retention? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"no significant difference"
] |
137 | 283 | 2361806 | Compared to Etoposide with 5-fluorouracil plus leucovorin (ELF) what was the result of Irinotecan with high-dose 5-fluorouracil plus leucovorin (ILF) on Overall survival? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | For ILF and ELF, respectively, median progression-free survival was 4.5 vs 2.3 months, time to treatment failure was 3.6 vs 2.2 months (P=0.4542), and overall survival was 10.8 vs 8.3 months (P=0.2818). | [
"no significant difference"
] |
138 | 397 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Procedure performed directly by the staff surgeon? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"no significant difference"
] |
139 | 233 | 3090298 | Compared to Thin-flap laser in situ keratomileusis (LASIK) what was the result of Photo-refractive keratectomy (PRK) on Corrected distance visual acuity at 6 months? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63. | [
"no significant difference"
] |
140 | 254 | 1831737 | Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on Patients infected with T. vaginalis? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful. | [
"no significant difference"
] |
141 | 282 | 2361806 | Compared to Etoposide with 5-fluorouracil plus leucovorin (ELF) what was the result of Irinotecan with high-dose 5-fluorouracil plus leucovorin (ILF) on Time to treatment failure? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | For ILF and ELF, respectively, median progression-free survival was 4.5 vs 2.3 months, time to treatment failure was 3.6 vs 2.2 months (P=0.4542), and overall survival was 10.8 vs 8.3 months (P=0.2818). | [
"no significant difference"
] |
142 | 385 | 2721929 | Compared to Bladder training only (BT) what was the result of Bladder training plus tolterodine (Co) on Urgency score improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Mean urgency score decreased by 44.8%, 62.2% and 60.2% in the BT, To, and Co groups, respectively, and the improvement was significantly greater in the To and Co groups than in the BT group (p<0.05 for each). | [
"significantly increased"
] |
143 | 467 | 3387601 | Compared to intravenous immunoglobulin (IVIG) what was the result of plasma exchange (PE) on negative correlation between CSF protein and duration of mechanical ventilation? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Examining the treatment groups separately, the significant negative correlation remained for the PE group (p-value = 0.037) and not for the IVIG group (p-value 0.132) | [
"significantly increased"
] |
144 | 273 | 2691927 | Compared to Conventional open approach what was the result of Laparoscopic surgery on Time to nasogastric decompression? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure. | [
"no significant difference"
] |
145 | 456 | 3446002 | Compared to control group what was the result of single dose of 50 mg/kg clofibrate on side effects? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | On serial daily examination during phototherapy and up to 2 days after that no problems or side effects were observed. Also for a period of two months no complication was detected. | [
"no significant difference"
] |
146 | 269 | 2691927 | Compared to Conventional open approach what was the result of Laparoscopic surgery on Hospital permanence? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure. | [
"no significant difference"
] |
147 | 463 | 1876597 | Compared to artemether-lumefantrine what was the result of dihydroartemisinin-piperaquine on Adverse Events? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Overall, there was no difference in the proportion of study participants who experienced any adverse event of moderate or greater severity between the DP (46%) and AL (42%) treatment groups (p = 0.47). | [
"no significant difference"
] |
148 | 238 | 3090298 | Compared to Pre-surgery baseline what was the result of Photo-refractive keratectomy (PRK) on Contrast sensitivity at 3 months seen at 3 cpd? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63. | [
"no significant difference"
] |
149 | 265 | 2691927 | Compared to Conventional open approach what was the result of Laparoscopic surgery on Visual analog scale pain score at day 3? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure. | [
"significantly decreased"
] |
150 | 395 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Average patient's weight? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"no significant difference"
] |
151 | 264 | 2691927 | Compared to Conventional open approach what was the result of Laparoscopic surgery on Visual analog scale pain score at day 1? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure. | [
"significantly decreased"
] |
152 | 370 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Cough score improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
153 | 479 | 2447617 | Compared to placebo what was the result of progesterone on The analysis using the dichotomization of GOS scores at 3 months post injury? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The percentage of favorable outcome was 58% for the patients who were given progesterone and was 42% in the placebo group (P = 0.048). Forty-one percent of patients who were given progesterone and 57% of the placebo group exhibited an unfavorable outcome (P = 0.048). | [
"significantly increased"
] |
154 | 261 | 1831737 | Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on Programme meeting attendance? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful. | [
"significantly increased"
] |
155 | 387 | 2721929 | Compared to Tolterodine only (To) what was the result of Bladder training plus tolterodine (Co) on Urgency score improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Mean urgency score decreased by 44.8%, 62.2% and 60.2% in the BT, To, and Co groups, respectively, and the improvement was significantly greater in the To and Co groups than in the BT group (p<0.05 for each). | [
"no significant difference"
] |
156 | 237 | 3090298 | Compared to Pre-surgery baseline what was the result of Photo-refractive keratectomy (PRK) on Contrast sensitivity at 1 month seen at 3 cpd? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63. | [
"significantly decreased"
] |
157 | 423 | 1187893 | Compared to No exercise what was the result of Exercise on Knee injury and Osteoarthritis Outcome Score quality of life subscale at 6 months? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | In the exercise group, an improvement was seen at 6 weeks in the KOOS subscale quality of life compared to the control group (mean change 4.0 vs. -0.7, p = 0.05). The difference between groups was still persistent at 6 months (p = 0.02). | [
"significantly increased"
] |
158 | 323 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Mean FEV1 at 12 hours on the day of randomization? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
159 | 316 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on 1-hour post-dose FEV1 improvements? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
160 | 217 | 1475568 | Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Baseline hypertension? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline. | [
"no significant difference"
] |
161 | 258 | 1831737 | Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on Intake of STI treatment? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful. | [
"no significant difference"
] |
162 | 441 | 2600646 | Compared to dihydroartemisinin-piperaquine (AP) what was the result of arthemeter-lumefantrine (AL) on Adverse events? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Final mean Hb levels were 7.15 mmol/l ± 1.07 for the DP treatment group and 6.79 mmol/l ± 1.24 for the AL group. A possible influence of anaemia on gametocyte carriage at enrollment was not observed in the present study (p > 0.05). | [
"no significant difference"
] |
163 | 377 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on 24-hour urinary cortisol at 6 months? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly decreased"
] |
164 | 218 | 1475568 | Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Baseline diabetes? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline. | [
"no significant difference"
] |
165 | 255 | 1831737 | Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on Secondary school education? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful. | [
"no significant difference"
] |
166 | 393 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Pain on day three after surgery? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"significantly decreased"
] |
167 | 473 | 2847809 | Compared to Placebo what was the result of Clopidogrel on First hemodialysis success? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The primary AVF failures at two months were 21.6% in placebo group and 5.2% in clopidogrel group (P = 0.03). | [
"significantly increased"
] |
168 | 228 | 1475568 | Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Baseline life-quality score? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline. | [
"no significant difference"
] |
169 | 401 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Cardiac complications? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"no significant difference"
] |
170 | 310 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Time to discontinuation? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
171 | 355 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Breathlessness Cough and Sputum Scale improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
172 | 427 | 1187893 | Compared to No exercise what was the result of Exercise on Functional performance improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | In the exercise group, an improvement was seen at 6 weeks in the KOOS subscale quality of life compared to the control group (mean change 4.0 vs. -0.7, p = 0.05). The difference between groups was still persistent at 6 months (p = 0.02). | [
"no significant difference"
] |
173 | 391 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Pain on day one after surgery? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"significantly decreased"
] |
174 | 384 | 2721929 | Compared to Bladder training only (BT) what was the result of Tolterodine only (To) on Urgency score improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Mean urgency score decreased by 44.8%, 62.2% and 60.2% in the BT, To, and Co groups, respectively, and the improvement was significantly greater in the To and Co groups than in the BT group (p<0.05 for each). | [
"significantly increased"
] |
175 | 259 | 1831737 | Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on Self-reported STI symptoms? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful. | [
"no significant difference"
] |
176 | 407 | 2690844 | Compared to Midline incision what was the result of Transverse incision on Better cosmetic appearance of the incision as subjectively assessed by patients? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30). | [
"significantly increased"
] |
177 | 226 | 1475568 | Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Knowledge about heart failure? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline. | [
"significantly increased"
] |
178 | 368 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Dyspnoea score improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
179 | 257 | 1831737 | Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on Genital discharge history? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful. | [
"no significant difference"
] |
180 | 220 | 1475568 | Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Baseline beta-blockers intake? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline. | [
"no significant difference"
] |
181 | 369 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Breathlessness Cough and Sputum Scale improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
182 | 250 | 2922723 | Compared to Usual airway clearance techniques what was the result of High frequency chest wall oscillation on Visual analogue scale scores for efficacy? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Patients scored the efficacy of their usual ACT significantly higher than for HFCWO (mean difference 14 mm; p=0.002). | [
"significantly decreased"
] |
183 | 450 | 2720945 | Compared to placebo what was the result of cineole on Side effects? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The difference between the two treatment groups was neither clinically relevant nor statistically significant. Safety examinations of the global assessment showed no difference between the two treatment groups. | [
"no significant difference"
] |
184 | 232 | 3090298 | Compared to Thin-flap laser in situ keratomileusis (LASIK) what was the result of Photo-refractive keratectomy (PRK) on Corrected distance visual acuity at 1 month? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63. | [
"significantly decreased"
] |
185 | 227 | 1475568 | Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Self-efficacy? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline. | [
"significantly increased"
] |
186 | 477 | 2447617 | Compared to placebo what was the result of progesterone on The mean intracranial pressure values 72 hours and 7 days after injury? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The percentage of favorable outcome was 58% for the patients who were given progesterone and was 42% in the placebo group (P = 0.048). Forty-one percent of patients who were given progesterone and 57% of the placebo group exhibited an unfavorable outcome (P = 0.048). | [
"no significant difference"
] |
187 | 281 | 2361806 | Compared to Etoposide with 5-fluorouracil plus leucovorin (ELF) what was the result of Irinotecan with high-dose 5-fluorouracil plus leucovorin (ILF) on Overall response rates? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | For ILF and ELF, respectively, median progression-free survival was 4.5 vs 2.3 months, time to treatment failure was 3.6 vs 2.2 months (P=0.4542), and overall survival was 10.8 vs 8.3 months (P=0.2818). | [
"significantly increased"
] |
188 | 266 | 2691927 | Compared to Conventional open approach what was the result of Laparoscopic surgery on Visual analog scale pain score at day 7? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure. | [
"significantly decreased"
] |
189 | 380 | 3580134 | Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 160/9 μg on Incidence of pneumonia? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"no significant difference"
] |
190 | 256 | 1831737 | Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on Spatial mobility? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful. | [
"no significant difference"
] |
191 | 285 | 2361806 | Compared to Etoposide with 5-fluorouracil plus leucovorin (ELF) what was the result of Irinotecan with high-dose 5-fluorouracil plus leucovorin (ILF) on Grade 3/4 digestive system toxic events? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | For ILF and ELF, respectively, median progression-free survival was 4.5 vs 2.3 months, time to treatment failure was 3.6 vs 2.2 months (P=0.4542), and overall survival was 10.8 vs 8.3 months (P=0.2818). | [
"significantly increased"
] |
192 | 361 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Dyspnoea score improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
193 | 365 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Sleep score improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
194 | 461 | 1876597 | Compared to artemether-lumefantrine what was the result of dihydroartemisinin-piperaquine on unadjusted risk of recurrent falciparum parasitemia? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Overall, there was no difference in the proportion of study participants who experienced any adverse event of moderate or greater severity between the DP (46%) and AL (42%) treatment groups (p = 0.47). | [
"significantly decreased"
] |
195 | 328 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Baseline-adjusted average 12-hour FEV1 on the day of randomization? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
196 | 386 | 2721929 | Compared to Tolterodine only (To) what was the result of Bladder training plus tolterodine (Co) on Micturition frequency? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Mean urgency score decreased by 44.8%, 62.2% and 60.2% in the BT, To, and Co groups, respectively, and the improvement was significantly greater in the To and Co groups than in the BT group (p<0.05 for each). | [
"no significant difference"
] |
197 | 363 | 3580134 | Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Cough score improvement? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6]. | [
"significantly increased"
] |
198 | 452 | 2720945 | Compared to placebo what was the result of cineole on Mean of sum of number, duration and severity of exacerbations during 6 months of treatment? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The difference between the two treatment groups was neither clinically relevant nor statistically significant. Safety examinations of the global assessment showed no difference between the two treatment groups. | [
"significantly decreased"
] |
199 | 455 | 3446002 | Compared to control group what was the result of single dose of 50 mg/kg clofibrate on The duration of phototherapy? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | On serial daily examination during phototherapy and up to 2 days after that no problems or side effects were observed. Also for a period of two months no complication was detected. | [
"significantly decreased"
] |